Skip to main content
. 2024 Jan 12;6(5):708–720. doi: 10.1016/j.cjco.2024.01.001

Figure 4.

Figure 4

Forest plot for (A) major adverse cardiovascular events; (B) death, (C) stent thrombosis, and (D) bleeding 1 year after percutaneous coronary intervention. AFIRE, Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease; CI, confidence interval; df, degrees of freedom; M-H, Mantel-Haenszel; OAC-ALONE, Optimizing Antithrombotic Care in Patients With Atrial Fibrillation and Coronary Stent.